Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)12.21
  • Today's Change0.072 / 0.60%
  • Shares traded39.22k
  • 1 Year change+66.05%
  • Beta1.6533
Data delayed at least 15 minutes, as of Sep 19 2024 20:56 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of DKK
(except for per share items)
Fiscal data as of Dec 31 202320232022
ASSETS
Cash And Short Term Investments1,8672,845
Total Receivables, Net1,827535
Total Inventory1,644919
Prepaid expenses19154
Other current assets, total4632
Total current assets5,4034,485
Property, plant & equipment, net2,4531,751
Goodwill, net----
Intangibles, net6,4825,943
Long term investments----
Note receivable - long term----
Other long term assets115.09
Total assets14,35312,391
LIABILITIES
Accounts payable954606
Accrued expenses420228
Notes payable/short-term debt00
Current portion long-term debt/capital leases471,130
Other current liabilities, total1,367323
Total current liabilities2,7882,287
Total long term debt9963
Total debt1451,193
Deferred income tax29--
Minority interest----
Other liabilities, total1,0982,891
Total liabilities4,0135,241
SHAREHOLDERS EQUITY
Common stock781707
Additional paid-in capital----
Retained earnings (accumulated deficit)9,5046,436
Treasury stock - common(1.54)(1.46)
Unrealized gain (loss)4632
Other equity, total11(24)
Total equity10,3407,150
Total liabilities & shareholders' equity14,35312,391
Total common shares outstanding7871
Treasury shares - common primary issue0.040.07
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.